Nasopharyngeal carcinoma marker and application thereof
A nasopharyngeal carcinoma and marker technology, which is applied to nasopharyngeal carcinoma markers and their application fields, can solve the problems of lack of trauma and high sensitivity, and achieves low price, high sensitivity and specific effects.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0023] Example 1 Comparison of the positive proportion of TREM-2 in peripheral blood CD8 lymphocytes and CD14 monocytes of nasopharyngeal carcinoma patients
[0024] 1. Collection of test samples: The peripheral blood of the subjects was collected, including 45 healthy people and 40 nasopharyngeal cancer patients.
[0025] 2. The detection method specifically includes the following steps:
[0026] (1) Use lymphocyte separation medium to separate PBMC from peripheral blood, take 1×10 5 ~1×10 7 cells, add 1 mL of PBS, and centrifuge at 1500 rpm for 5 minutes;
[0027] (2) Specific antibody staining reaction: 100 μL reaction system contains: PBMC is 1x10 5 ~1x10 7 cells, 100 μL of PBS, 3 μL of TREM-2 antibody or isotype control antibody IgG, 2 μL of CD14 antibody, and 2 μL of CD8 antibody, and the above reaction system was placed on ice (0-4°C) and incubated in the dark for 30 minutes. Add 1 mL of PBS, centrifuge at 1500 rpm for 5 minutes, repeat 3 times;
[0028] (3) Add 5...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com